A study by the Centers for Disease Control and Prevention (CDC) analyzed survey data from July to August 2025, involving over 8,000 US adults. The findings indicate that approximately 9.8% of US adults, or about 27 million people, used a glucagon-like peptide-1 receptor agonist (GLP-1 medication) in 2025. This data was published in the CDC’s Morbidity and Mortality Weekly Report.
The study revealed that nearly half (44%) of GLP-1 users reported taking their medication differently than prescribed. This included actions such as skipping doses, delaying refills, or using smaller doses. This suggests a significant portion of users are not following medical instructions for these potent drugs.
More than half of individuals who modified their GLP-1 usage attributed these changes to issues with cost or drug availability. These barriers were particularly pronounced among younger users; 58% of adults aged 14–39 cited cost as a reason for modifying use, compared to 20% of adults 65 or older.
The study also highlighted the use of compounded GLP-1 medications. Among all GLP-1 users, at least 23% reported using a compounded version. An additional 9% were unsure whether their medication was compounded, indicating a lack of clarity for some users regarding their drug's origin.
The widespread modified use of GLP-1 drugs, especially with unapproved or compounded versions, raises questions about the real-world safety and efficacy of these medications. Deviations from prescribed regimens can impact treatment outcomes and potentially introduce unforeseen health risks.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
A CDC study found that nearly half of GLP-1 medication users in the US, approximately 12 million adults, are not taking their drugs as prescribed. The primary reasons cited for modified use were cost and availability, with younger adults more affected by cost barriers.